Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration

Maguire, Maureen G., Martin, Daniel F., Ying, Gui-shuang, Jaffe, Glenn J., Daniel, Ebenezer, Grunwald, Juan E., Toth, Cynthia A., Ferris, Frederick L., Fine, Stuart L.·2016·Ophthalmology

DOI 10.1016/j.ophtha.2016.03.045

Cited by (706)

Items 301–400 of 706

Radial shape discrimination testing for new-onset neovascular age-related macular degeneration in at-risk eyes
Noelia Pitrelli Vazquez, Simon Peter Harding, Heinrich Heimann, Gabriela Czanner, Paul C. Knox · 2018 · PLoS ONE
Efficacy and Cost-Effectiveness of Anti-VEGF for Treating Diabetic Retinopathy in the Indian Population
Subhasish Pramanik, Lakshmi Kanta Mondal, Suman Kalyan Paine, Sneha Jain, Subhankar Chowdhury, Upasana Ganguly, Sayantan Ghosh, Chiranjit Bose, Koena Bhattacharjee, Gautam Bhaduri · 2021 · Clinical ophthalmology
Treat‐and‐extend regimens of anti‐vascular endothelial growth factor therapy for retinal vein occlusions: a systematic review and meta‐analysis
Keean Nanji, Mohammad Daud Khan, Muhammad F. Khalid, Jim Shenchu Xie, Gurkaran S. Sarohia, Mark Phillips, Lehana Thabane, Sunir J. Garg, Peter K. Kaiser, Sobha Sivaprasad et al. · 2021 · Acta Ophthalmologica
Antibody blockade of Jagged1 attenuates choroidal neovascularization
Torleif Tollefsrud Gjølberg, Jonas Aakre Wik, Hanna Johannessen, Stig Krüger, Nicola Bassi, PANAGIOTIS F. CHRISTOPOULOS, Malin Bern, Stian Foss, Goran Petrovski, Morten C. Moe et al. · 2023 · Nature Communications
Looking to the Future of Viral Vectors in Ocular Gene Therapy: Clinical Review
Chulpan Bulatovna Kharisova, Kristina Viktorovna Kitaeva, Valeriya V. Solovyeva, Albert Akramovich Sufianov, Г. З. Суфианова, Р Ф Ахметшин, S N Bulgar, Albert Anatolyevich Rizvanov · 2025 · Biomedicines
Injektionsstrategien bei der Anwendung intravitrealer VEGF-Inhibitoren: „Pro Re Nata versus Treat and Extend“
Katerina Hufendiek, Amelie Pielen, Carsten Framme · 2017 · Klinische Monatsblätter für Augenheilkunde
Impact of Intravitreal Ranibizumab Therapy on Vision Outcomes in Diabetic Macular Edema Patients: A Meta-Analysis
Manuel Sousa Falcão · 2019 · Ophthalmologica
Treatment of neovascular age related macular degeneration during COVID-19 pandemic: The short term consequences of unintended lapses
Mehmet Ali Şekeroğlu, Hilal Kılınç Hekimsoy, Tugce Horozoglu Ceran, Sibel Doğuizi · 2021 · European Journal of Ophthalmology
Polyphenols and Posterior Segment Eye Diseases: Effects on Angiogenesis, Invasion, Migration and Epithelial-Mesenchymal Transition
Miłosz Caban, Urszula Lewandowska · 2021 · Food Reviews International
Selectively targeting disease‐restricted secretogranin III to alleviate choroidal neovascularization
Liyang Ji, Prabuddha Waduge, Lili Hao, Avinash Kaur, Wencui Wan, Yan Ling Wu, Hong Tian, Jinsong Zhang, Keith A. Webster, Wei Li · 2021 · The FASEB Journal
Age differential response to bevacizumab therapy in choroidal neovascularization in rabbits
Van Phuc Nguyen, Jessica Henry, Josh Zhe, Quynh Kieu, Wei Ping Qian, Yingbin Fu, Xueding Wang, Yannis Mantas Paulus · 2022 · Experimental Eye Research
LONG-TERM REMISSION OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH AS-NEEDED ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
İlkay Kılıç Müftüoğlu, Mostafa Mohamed Ragheb Alam, Qi Sheng You, Raouf Ahmed Gaber, Hema L. Ramkumar, Nadia Mendoza, Amit Meshi, William R. Freeman · 2017 · Retina
SUSPENDING TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN CASES OF FUTILITY
David T. Wong, George N. Lambrou, Anat Loewenstein, Ian Pearce, Annabelle Ayame Okada · 2019 · Retina
Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an update
Ciro Costagliola, Francesco Morescalchi, Sarah Duse, Davide Romano, Giuseppina Mazza, Francesco Parmeggiani, Silvia Bartollino, Francesco Semeraro · 2019 · Expert Opinion on Drug Safety
Pain related to intravitreal injections for age-related macular degeneration: a qualitative study of the perspectives of patients and practitioners
Christina Yiallouridou, Jennifer H. Acton, Sanjiv Banerjee, Heather A. Waterman, Ashley Wood · 2023 · BMJ Open
Interim Results of the Phase III Portal Extension Trial of the Port Delivery System with Ranibizumab in Neovascular Age-Related Macular Degeneration
Peter A. Campochiaro, David A. Eichenbaum, MARGARET A. CHANG, W. Lloyd Clark, Jordan M. Graff, Sophie Le Pogam, Melina Cavichini Cordeiro, Shamika Gune, Melvin Rabena, Natasha Singh et al. · 2024 · Ophthalmology Retina
Wearable electrodriven switch actively delivers macromolecular drugs to fundus in non-invasive and controllable manners
Xuan Qin, Haoliang Shi, Hongyang Li, Binbin Chu, Jiawei Zhang, Zhen Wen, Xuhui Sun, Houyu Wang, Yao He · 2025 · Nature Communications
Management of Fluid in Neovascular Age-related Macular Degeneration: To Mop it, to Dab it, or to Leave it?
Ashish Sharma, Nilesh Kumar, Sonali Singh, Carl D. Regillo, K. Bailey Freund · 2020 · Retina
Elucidation of Pathophysiology and Novel Treatment for Diabetic Macular Edema Derived from the Concept of Neurovascular Unit
Yoshihiko Usui · 2020 · JMA Journal
Nonclinical Toxicology and Biocompatibility Program Supporting Clinical Development and Registration of the Port Delivery System With Ranibizumab for Neovascular Age-Related Macular Degeneration
Vladimir Bantseev, Joshua D. Horvath, Giulio Barteselli, Shrirang V. Ranade, Mauricio Maia, Daniela Bumbaca Yadav, Chris Schuetz, Amy Shelton, Helen S. Booler · 2020 · Toxicologic Pathology
Long-term outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
Ki Won Jin, Jae Hui Kim, Jun Young Park, Sang Jun Park, Kyu Hyung Park, Joo Yong Lee, Se Joon Woo · 2021 · Scientific Reports
Real-world effectiveness of screening programs for age-related macular degeneration: amended Japanese specific health checkups and augmented screening programs with OCT or AI
Hiroshi Tamura, Yoko Akune, Yoshimune Hiratsuka, Ryo Kawasaki, Ai Kido, Masahiro Miyake, Rei Goto, Masakazu Yamada · 2022 · Japanese Journal of Ophthalmology
Switch to Aflibercept in the Treatment of Neovascular AMD: Long-Term Results
Pedro Cardoso, Ana Fernanda Pinheiro, Jorge Meira, Ana Catarina Pedrosa, Manuel Sousa Falcão, João Pinheiro-Costa, Fernando Falcão‐Reis, Ângela M. Carneiro · 2017 · Journal of Ophthalmology
Device design methodology and formulation of a protein therapeutic for sustained release intraocular delivery
Erica B. Schlesinger, Daniel A. Bernards, Hunter H. Chen, James Feindt, Jingtai Cao, Daniel Dix, Carmelo Romano, Robert B. Bhisitkul, Tejal Ashwin Desai · 2018 · Bioengineering & Translational Medicine
Cluster endophthalmitis due to Stenotrophomonas maltophilia following intravitreal bevacizumab: outcomes of patients from North India
Aniruddha Kishandutt Agarwal, Kanika Aggarwal, Ramanuj Samanta, Archana Angrup, Manisha Biswal, Pallab Ray, Mohit Dogra, Deeksha Katoch, Reema Bansal, Ramandeep Singh et al. · 2018 · British Journal of Ophthalmology
Comparison of Automated versus Manually Modified OCT Angiography En Face Slabs for Detection of Choroidal Neovascularization
Robert Siggel, Christel Spital, Anna M. Lentzsch, Sandra Liakopoulos · 2019 · Ophthalmology Retina
Stellungnahme der DOG, der RG und des BVA zur Anti-VEGF-Therapie bei der neovaskulären altersabhängigen Makuladegeneration
Deutsche Ophthalmologische Gesellschaft (DOG), Retinologische Gesellschaft e. V. (RG), Berufsverband der Augenärzte Deutschlands e. V. (BVA) · 2020 · Der Ophthalmologe
Ten-year survival trends of neovascular age-related macular degeneration at first presentation
Cristina Arpa, Hagar Khalid, Shruti Chandra, Siegfried K. Wagner, Katrin Fasler, Livia Faes, Pakinee Pooprasert, Reena Chopra, Gabriella Moraes, Konstantinos Balaskas et al. · 2020 · British Journal of Ophthalmology
The Association Between Metformin Use and New-Onset ICD Coding of Geographic Atrophy
John T. Moir, Max J. Hyman, Reem Gonnah, Andrea Flores, Seenu M. Hariprasad, Dimitra Skondra · 2024 · Investigative Ophthalmology & Visual Science
Impact of residual retinal fluid on treatment outcomes in neovascular age-related macular degeneration
Dinah Zur, Robyn H. Guymer, Jean‐François Korobelnik, Lihteh Wu, Francesco Viola, Nicole Eter, Stéphanie Baillif, Youxin Chen, Jennifer Arnold · 2024 · British Journal of Ophthalmology
Three-month outcomes of treatment with faricimab or aflibercept for neovascular age-related macular degeneration: a propensity score matching study in a Japanese population
Yosuke Fukuda, Shoji Notomi, Satomi Shiose, Yusuke Maehara, Kohei Kiyohara, Kohta Fujiwara, Sawako Hashimoto, Kumiko Kano, Keijiro Ishikawa, Toshio Hisatomi et al. · 2024 · Graefe s Archive for Clinical and Experimental Ophthalmology
Utilizing aptamers in targeted protein degradation strategies for disease therapy
Lin Li, Songbo Xie, Jun Zhou, Jie Ran · 2025 · The Journal of Pathology
Five-year Outcomes of Ranibizumab in Neovascular Age-related Macular Degeneration: Real Life Clinical Experience
Abdullah Özkaya, Zeynep Alkın, Mesut Toğaç, Sibel Ahmet, İrfan Perente, Muhittin Taşkapılı · 2017 · Korean Journal of Ophthalmology
ARMS2 A69S polymorphism is associated with the number of ranibizumab injections needed for exudative age-related macular degeneration in a pro re nata regimen during 4 years of follow-up
Alicia Valverde-Megías, S. Veganzones, J. Donate-López, Maria Luisa Maestro-de-las-Casas, Alicia Megías-Fresno, Julian Garcia-Sanchez · 2017 · Graefe s Archive for Clinical and Experimental Ophthalmology
Retinal pigment epithelial atrophy after anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy
Han Joo Cho, Kunhae Kim, Soo Hyun Lim, Dong Hyun Kang, Jong Woo Kim · 2020 · British Journal of Ophthalmology
A Review of Macular Atrophy of the Retinal Pigment Epithelium in Patients with Neovascular Age-Related Macular Degeneration: What is the Link? Part II
Mania Horani, Sajjad Mahmood, Tariq Mehmood Aslam · 2020 · Ophthalmology and Therapy
Essential contribution of macrophage Tie2 signal mediated autophagy in laser-induced choroidal neovascularization
Bingyu Zhang, Xue Yin, Jianqing Li, Chi Ren, Weiming Liu, Gaoqin Liu, Peirong Lu · 2020 · Experimental Eye Research
Correlation of Baseline Visual Acuity with Outcomes of Treatment with Anti-VEGF in Neovascular Age-Related Macular Degeneration
Balaji Veluswamy, Andy Hung-Yi Lee, Rukhsana G. Mirza, Manjot K. Gill · 2020 · Clinical ophthalmology
Age-Related Macular Degeneration and Its Association With Neurodegenerative Disorders
Sankalp Mody, Abhishek Joshi · 2023 · Cureus
Intravitreal bevacizumab monotherapy in myopic choroidal neovascularisation: 5-year outcomes for the PAN-American Collaborative Retina Study Group
Jay Kumar Chhablani, Remya Mareen Paulose, Andrés F. Lasave, Lihteh Wu, Cristián Carpentier, Maurício Maia, Silvio Lujan, Sergio Rojas, Martin A. Serrano, María H. Berrocal et al. · 2017 · British Journal of Ophthalmology
Factors associated with extended remission in neovascular age-related macular degeneration on pro re nata treatment protocol
Tiezhu Lin, Kunny Dans, İlkay Kılıç Müftüoğlu, Amit Meshi, Manuel J. Amador-Patarroyo, Lingyun Cheng, William R. Freeman · 2019 · British Journal of Ophthalmology
PREDICTORS OF RECURRENT EXUDATION IN CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION DURING A TREATMENT-FREE PERIOD
Taiichi Hikichi, Mitsuko Agarie, Natsuki Kubo, Moe Yamauchi · 2020 · Retina
Intraocular delivery considerations of ocular biologic products and key preclinical determinations
Patrick M. Hughes, Hongwen M. Rivers, Vladimir Bantseev, Chun‐Wan Yen, Hanns‐Christian Mahler, Swati Gupta · 2023 · Expert Opinion on Drug Delivery
Levels of complement factor H-related 4 protein do not influence susceptibility to age-related macular degeneration or its course of progression
Moussa A. Zouache, B. T. Richards, Chris M. Pappas, Robert A. Anstadt, J. Liu, T. Corsetti, S. Matthews, Nathan A. Seager, Steffen Schmitz-Valckenberg, Monika Fleckenstein et al. · 2024 · Nature Communications
Progress in the Application of Microneedles in Eye Disorders and the Proposal of the Upgraded Microneedle with Spinule
Qiannan Yang, Tingting Zhang, Yujie Wu, Qianyue Liang, Wanqi Zhao, Rui Liu, Xin Jin · 2024 · Pharmaceutical Research
Visual and Anatomic Responses in Patients With Neovascular Age-Related Macular Degeneration and a Suboptimal Response to Anti-VEGF Therapy Switched to Faricimab
Ali Khodor, Stephanie K. Y. Choi, Tavish Nanda, Jonathan Thomas Caranfa, Raul E. Ruiz‐Lozano, Shilpa H. Desai, Michelle C. Liang, Caroline R. Baumal, David C. Reed, Tina Scheufele Cleary et al. · 2024 · Journal of VitreoRetinal Diseases
Gene therapy for geographic atrophy in age-related macular degeneration: current insights
Muhammad Usman Jamil, Nadia Khalida Waheed · 2024 · Eye
The Economic Burden of Anti-Vascular Endothelial Growth Factor on Patients and Caregivers in the UK, Europe, and North America
David C. Tabano, Arjun Watane, Richard Peter Gale, Oliver Cox, Sarah Hill, Louise Longworth, Yemi Oluboyede, Ayesha M. Ahmed, Nimesh A. Patel · 2025 · Ophthalmology and Therapy
Innovation in Neovascular Age-Related Macular Degeneration: Consideration of Brolucizumab, Abicipar, and the Port Delivery System
Charles C. Wykoff, Brenda Zhou, Seenu M. Hariprasad · 2018 · Ophthalmic surgery, lasers & imaging retina
Effect of COVID-19 Lockdown in Spain on Structural and Functional Outcomes of Neovascular AMD Patients
Alicia Valverde-Megías, Daniela Rego Lorca, José Ignacio Fernández‐Vigo, Antonio Murciano, Alicia Megías-Fresno, Julián García-Feijoo · 2021 · Journal of Clinical Medicine
Optical coherence tomography angiography for the detection of macular neovascularization—comparison of en face versus cross-sectional view
Robert Siggel, Christel Spital, Anna M. Lentzsch, Sandra Liakopoulos · 2022 · Eye
Anti-angiogenic properties of rapamycin on human retinal pericytes in an in vitro model of neovascular AMD via inhibition of the mTOR pathway
Ben Asani, Jakob Siedlecki, Christian Maximilian Wertheimer, Raffael Gi-Hwan Liegl, Armin Wolf, Andreas Ohlmann, Siegfried Georg Priglinger, Claudia Priglinger · 2022 · BMC Ophthalmology
Association between structural and functional treatment outcomes in neovascular age‐related macular degeneration
Hauraz Haji, Christina Gianniou, Troels Brynskov, Torben Lykke Sørensen, Rasmus Huan Olsen, Marie Krogh Nielsen · 2022 · Acta Ophthalmologica
Neovascular age-related macular degeneration without exudative recurrence over 24 months after initial remission
Han Joo Cho, Young Joon Jeon, Wontae Yoon, Jihyun Yoon, Jaemin Kim, Jong Woo Kim · 2022 · Scientific Reports
Lesion area progression in eyes with neovascular age-related macular degeneration treated using a proactive or a reactive regimen
Mariano Cozzi, Davide Monteduro, Raffaele Antonio Esposito, Kimberly Spooner, Samantha Fraser‐Bell, Giovanni Staurenghi, Francesco Romano, Matteo Airaldi, Andrew Chang, Alessandro Invernizzi · 2023 · Eye
Differences in Central and Peripheral Choroidal Thickness among the Subtypes of Age-Related Macular Degeneration in an Asian Population
Yosuke Fukuda, Shoji Notomi, Satomi Shiose, Kumiko Kano, Sawako Hashimoto, Kohta Fujiwara, Masato Akiyama, Keijiro Ishikawa, Toshio Hisatomi, Koh‐Hei Sonoda · 2023 · Journal of Clinical Medicine
Four-Year Outcome of Aflibercept Treatment-Naïve Patients for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting
Y. Gayadine-Harricham, Virginie Rufin, Sandrine Law-Koune, Thi Hà Châu Tran · 2020 · Journal of Ophthalmology
Analysis of Long Noncoding RNAs in Choroid Neovascularization
Pengfei Zhang, Bing Lu, Fengyuan Xu, Chen Wang, Rongrong Zhang, Yinping Liu, Chenghua Wei, Lixin Mei · 2020 · Current Eye Research · Retracted
Ranibizumab treatment patterns in prior ranibizumab-treated neovascular age-related macular degeneration patients: Real-world outcomes from the LUMINOUS study
Frank Gerhard Holz, Angelo Maria Minnella, Raman Tuli, Pradeepa Yoganathan, Soumil Parikh, ROBIN D. HAMILTON, on behalf of the LUMINOUS™ study group · 2020 · PLoS ONE
Application of machine learning methods to bridge the gap between non-interventional studies and randomized controlled trials in ophthalmic patients with neovascular age-related macular degeneration
Alexandros Sagkriotis, Usha Chakravarthy, Ray Griner, Orla Doyle, Tim M Wintermantel, Andreas Clemens · 2021 · Contemporary Clinical Trials
The Role of the VEGF Signaling Pathway in Tumor Angiogenesis
Napoleone Ferrara · 2019 · Springer eBooks
Special Commentary: Early Clinical Development of Cell Replacement Therapy: Considerations for the National Eye Institute Audacious Goals Initiative
Leonard A. Levin, Joan W. Miller, Donald J. Zack, Martin Friedlander, Lois E. H. Smith · 2017 · Ophthalmology
Long-Term Management of Neovascular Age-Related Macular Degeneration: To Suspend or Not to Suspend?
Rahul N. Khurana · 2019 · Ophthalmology Retina
Persistence of Retinal Fluid after Anti-VEGF Treatment for Neovascular Age-Related Macular Degeneration
Dominic Wei Ting Yap, Benjamin Kye Jyn Tan, Kelvin Yi Chong Teo, Tien Yin Wong, Chui Ming Gemmy Cheung · 2025 · Ophthalmology Retina
Subjective and objective measures of the patient experience before, during, and after intravitreal anti–vascular endothelial growth factor injections
Suresh Mekala, Pankaja Dhoble, Vishwaraj C. R, Ashish Khodifad, Olivia M. Hess, GS Lavanya · 2021 · Indian Journal of Ophthalmology
Discontinuation and loss to follow-up rates in clinical trials of intravitreal anti-vascular endothelial growth factor injections
Tatiana R. Rosenblatt, Nadim Rayess, Ahmad Al‐Moujahed, Rahul N. Khurana, Prithvi Mruthyunjaya · 2021 · Graefe s Archive for Clinical and Experimental Ophthalmology
“What should I inject next?” Challenging treatment decisions in the multiple anti-VEGF: a review of publications exploring anti-VEGF switching for nAMD
Joseph Pikkel, Shira Attas · 2017 · International Ophthalmology
Impact of Baseline Characteristics on Treatment Response to Intravitreal Aflibercept Injection for Wet Age-Related Macular Degeneration
Allen C. Ho, Namrata Saroj, Keith H. Baker, Robert Vitti, Alyson J. Berliner, Desmond E. Thompson, Daniel B. Roth · 2017 · Ophthalmology Retina
Aqueous humour proteins and treatment outcomes of anti-VEGF therapy in neovascular age-related macular degeneration
Yusuke Arai, Hidenori Takahashi, Satoru Inoda, Xue Tan, Shinichi Sakamoto, Yuji Inoue, Yujiro Fujino, Hidetoshi Kawashima, Yasuo Yanagi · 2020 · PLoS ONE
Long-Term Follow-up of Patients with Exudative Age-Related Macular Degeneration Treated with Intravitreal Anti–Vascular Endothelial Growth Factor Injections
Felix F. Kung, Matthew R. Starr, Yvonne Bui, Camilo A. Mejía, Sophie J. Bakri · 2020 · Ophthalmology Retina
Long-term Outcomes of Treat and Extend Regimen of Anti-vascular Endothelial Growth Factor in Neovascular Age-related Macular Degeneration
Andy Lee, Pooja G Garg, Alice T. Lyon, Rukhsana G. Mirza, Manjot K. Gill · 2020 · Journal of Ophthalmic and Vision Research
AAV2-antiVEGFscFv gene therapy for retinal neovascularization
Ni Han, Xin Xu, Ying Liu, Guangzuo Luo · 2023 · Molecular Therapy — Methods & Clinical Development
Outcomes of Anti–Vascular Endothelial Growth Factor Treatment for Choroidal Neovascularization in Fellow Eyes of Previously Treated Patients With Neovascular Age-Related Macular Degeneration
Maxwell S. Stem, Omar Moinuddin, Noah Kline, Aristomenis Thanos, Prethy Rao, George A. Williams, T. Hassan · 2018 · JAMA Ophthalmology
Visual Outcome and Treatment Frequency of Anti-VEGF Therapy Using the Treat-and-Extend and Treatment Cessation Regimen for Exudative Age-Related Macular Degeneration and Pachychoroid Neovasculopathy
Takamasa Kinoshita, Junya Mori, Akira Hatanaka, Miho Shimizu, Hiroko Imaizumi · 2021 · Clinical ophthalmology
Effectiveness of bevacizumab step therapy for neovascular age-related macular degeneration
Jonathan C. Siktberg, Stephen Jae Kim, Paul W. Sternberg, Shriji N. Patel · 2022 · Eye
Learn Single-horizon Disease Evolution for Predictive Generation of Post-therapeutic Neovascular Age-related Macular Degeneration
Yuhan Zhang, Kun Huang, Mingchao Li, Songtao Yuan, Qiang Chen · 2023 · Computer Methods and Programs in Biomedicine
VEGF Induces Expression of Genes That Either Promote or Limit Relaxation of the Retinal Endothelial Barrier
Maximilian A. McCann, Yueru Li, Basma Baccouche, Andrius Kazlauskas · 2023 · International Journal of Molecular Sciences
Evolving multidimensional pharmacological approaches to CNV therapy in AMD
Moshe Ehrenberg, Ofra Benny · 2017 · Current Eye Research
Linking OCT, Angiographic, and Photographic Lesion Components in Neovascular Age-Related Macular Degeneration
Cynthia Ann Toth, Vincent Tai, Stephanie J. Chiu, Katrina Postell Winter, Monica B. Sevilla, Ebenezer Daniel, Juan E. Grunwald, Glenn J. Jaffe, Daniel Francis Martin, Gui‐Shuang Ying et al. · 2017 · Ophthalmology Retina
A Randomized Trial of a Short 34-Gauge Needle for Intravitreal Injections
Hirofumi Sasajima, K. Tsuboi, Hikari Ono, Kenta Murotani, Motohiro Kamei · 2018 · Ophthalmology
Amelotin is expressed in retinal pigment epithelium and localizes to hydroxyapatite deposits in dry age-related macular degeneration
Dinusha Rajapakse, Katherine M. Peterson, Sanghamitra Mishra, Jianguo Fan, Joshua E. Lerner, Maria Mercedes Campos, Graeme J. Wistow · 2020 · Translational research
Four-year outcomes of intravitreal aflibercept treatment for neovascular age-related macular degeneration using a treat-and-extend regimen in Japanese patients
Koki Ishibashi, Masatoshi Haruta, Yumi Ishibashi, Rie Noda, Shotaro Dake, Shigeo Yoshida · 2021 · Therapeutic Advances in Ophthalmology
Combination of AIBP, apoA-I, and Aflibercept Overcomes Anti-VEGF Resistance in Neovascular AMD by Inhibiting Arteriolar Choroidal Neovascularization
Zhao Zhang, Megan M. Shen, Yingbin Fu · 2022 · Investigative Ophthalmology & Visual Science
VEGF as a Trophic Factor for Müller Glia in Hypoxic Retinal Diseases
Shuhua Fu, Shuqian Dong, Meili Zhu, Yun-Zheng Le · 2018 · Advances in experimental medicine and biology
Systemic counterregulatory response of angiopoietin‐2 after aflibercept therapy for nAMD: a potential escape mechanism
Reinhard Angermann, Teresa Rauchegger, Yvonne Nowosielski, Christof Seifarth, Stefan F. Egger, Martina Theresa Kralinger, Gerhard Franz Kieselbach, Claus Zehetner · 2020 · Acta Ophthalmologica
Repurposing medications for treatment of age-related macular degeneration: Insights from novel approaches to data mining
John T. Moir, Sarthak Aggarwal, Dimitra Skondra · 2023 · Experimental Biology and Medicine
The Landscape of Vascular Endothelial Growth Factor Inhibition in Retinal Diseases
Joseph B. Lin, Rajendra S. Apte · 2025 · Investigative Ophthalmology & Visual Science
Recurrence of neovascular age-related macular degeneration after discontinuation of modified treat and extend treatment
Junwoo Lee, Jae‐Hwan Choi, Seung‐Young Yu, Kiyoung Kim · 2025 · Scientific Reports
Improved functional and morphological outcomes with faricimab in nAMD eyes with poor response to prior intravitreal anti-VEGF therapy
Nathalie Bleidißel, Matthias Weichenberger, Mathias M. Maier, Nina Spielberg, Nikolaus Feucht · 2025 · International Ophthalmology
Intravitreale operative Medikamenteneingabe (IVOM) – Qualitätssicherung in Westfalen-Lippe
J. Stasch-Bouws, S. M. Eller-Woywod, Stefanie Schmickler, J. Inderfurth, P. Hoffmann, C. Ohlmeyer, B. Kammering, Daniel Pauleikhoff · 2020 · Der Ophthalmologe
Enlargement rate of geographic atrophy before and after secondary CNV conversion with associated anti-VEGF treatment
Jakob Siedlecki, Caroline Koch, Benedikt Schworm, Raffael Gi-Hwan Liegl, Thomas Christian Kreutzer, Karsten Kortuem, Ricarda Gisela Schumann, Siegfried Georg Priglinger, Armin Wolf · 2021 · BMC Ophthalmology
Genomewide Association Study of Retinal Traits in the Amish Reveals Loci Influencing Drusen Development and Link to Age-Related Macular Degeneration
Michael D. Osterman, Yeunjoo E. Song, Muneeswar Gupta Nittala, Srinivas Reddy Sadda, William K. Scott, Dwight Stambolian, Margaret Ann Pericak‐Vance, Jonathan L. Haines · 2022 · Investigative Ophthalmology & Visual Science
Aptamers as Diagnostic and Therapeutic Agents for Aging and Age-Related Diseases
Tae-In Park, Ah Hyun Yang, Bashistha Kumar Kanth, Seung Pil Pack · 2025 · Biosensors
External Limiting Membrane Disruption Predicts Long-Term Outcome in Strict Treat-And-Extend Regimen in Neovascular Age-Related Macular Degeneration
Laura Hoffmann, Katja B. Hatz · 2021 · Frontiers in Medicine
Risk of Posterior Capsular Rupture during Phacoemulsification in Patients with the History of Anti‐VEGF Intravitreal Injections: Results from the Pan‐American Collaborative Retina Study (PACORES) Group
Raúl Vélez-Montoya, Idaira Sánchez-Santos, Mauricio Galván-Chávez, Lihteh Wu, J. Fernando Arévalo, María H. Berrocal, Arturo Alezzandrini, Marta S. Figueroa, Roberto Gallego‐Pinazo, Rosa Dolz‐Marco et al. · 2021 · Journal of Ophthalmology
Safety and Tolerability of Intravitreal Carotuximab (DE-122) in Patients With Persistent Exudative Age-Related Macular Degeneration: A Phase I Study
Víctor H. González, Brian B. Berger, Roger A. Goldberg, Carmelina M. Gordon, Rahul N. Khurana, Raymund Angeles, Naveed K. Shams · 2021 · Translational Vision Science & Technology
GSK3 Is a Central Player in Retinal Degenerative Diseases but a Challenging Therapeutic Target
Catherine Hottin, Muriel Perron, Jérôme E. Roger · 2022 · Cells
Recent Advances in Imaging Macular Atrophy for Late-Stage Age-Related Macular Degeneration
Anny M. S. Cheng, K V Chalam, Vikram S. Brar, David T.Y. Yang, Jineel Bhatt, Raphael G. Banoub, SHAILESH KUMAR GUPTA · 2023 · Diagnostics
Effects of Brimonidine on Retinal Pigment Epithelial Cells and Müller Cells Exposed to Amyloid-Beta 1–42 Peptide In Vitro
Sean W. Tsao, Rami Gabriel, Kunal Thaker, Baruch D. Kuppermann, M. Cristina Kenney · 2018 · Ophthalmic surgery, lasers & imaging retina
Critical Role of Trophic Factors in Protecting Müller Glia: Implications to Neuroprotection in Age-Related Macular Degeneration, Diabetic Retinopathy, and Anti-VEGF Therapies
Bei Xu, Huiru Zhang, Meili Zhu, Yun-Zheng Le · 2019 · Advances in experimental medicine and biology